Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Neuroleptic Drug Targets a Brain-Eating Amoeba: Effects of Promethazine on Neurotropic Acanthamoeba castellanii.

Baig AM, Katyara P, Rajabali MN, Khaleeq A, Nazim F, Lalani S.

ACS Chem Neurosci. 2019 May 15. doi: 10.1021/acschemneuro.9b00100. [Epub ahead of print]

PMID:
30977998
2.

Proposals for Amendments in the Diagnosis and Treatment of Encephalitis caused by Free-living Amoebae.

Baig AM.

Infect Disord Drug Targets. 2019 Apr 5. doi: 10.2174/1871526519666190405170601. [Epub ahead of print]

PMID:
30961516
3.

Human Genome-Edited Babies: First Responder with Concerns Regarding Possible Neurological Deficits!

Baig AM.

ACS Chem Neurosci. 2019 Jan 16;10(1):39-41. doi: 10.1021/acschemneuro.8b00668. Epub 2018 Dec 17.

PMID:
30556694
4.

Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis.

Baig AM.

Eye (Lond). 2019 May;33(5):698-701. doi: 10.1038/s41433-018-0306-x. Epub 2018 Dec 14. No abstract available.

PMID:
30552420
5.

Evidence of human-like Ca2+ channels and effects of Ca2+ channel blockers in Acanthamoeba castellanii.

Baig AM, Rana Z, Waliani N, Karim S, Rajabali M.

Chem Biol Drug Des. 2019 Mar;93(3):351-363. doi: 10.1111/cbdd.13421. Epub 2019 Jan 29.

PMID:
30362253
6.

Drug targeting in Acanthamoeba keratitis: rational of using drugs that are already approved for ocular use in non-keratitis indications.

Baig AM.

Eye (Lond). 2019 Mar;33(3):509-518. doi: 10.1038/s41433-018-0245-6. Epub 2018 Oct 24. No abstract available.

PMID:
30356128
7.

Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease.

Baig AM.

ACS Chem Neurosci. 2019 Jan 16;10(1):21-24. doi: 10.1021/acschemneuro.8b00409. Epub 2018 Aug 30.

PMID:
30160095
8.

Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae.

Baig AM.

Curr Drug Targets. 2019;20(1):60-69. doi: 10.2174/1389450119666180426100452.

PMID:
29697029
9.

DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction.

Baig AM.

ACS Chem Neurosci. 2018 Oct 17;9(10):2299-2303. doi: 10.1021/acschemneuro.8b00137. Epub 2018 Apr 19.

PMID:
29671582
10.

Evolution of pH buffers and water homeostasis in eukaryotes: homology between humans and Acanthamoeba proteins.

Baig AM, Zohaib R, Tariq S, Ahmad HR.

Future Microbiol. 2018 Feb;13:195-207. doi: 10.2217/fmb-2017-0116. Epub 2018 Jan 11.

PMID:
29322818
11.

Drug Target Discovery Methods In Targeting Neurotropic Parasitic Amoebae.

Baig AM, Waliani N, Karim S.

ACS Chem Neurosci. 2018 Feb 21;9(2):162-164. doi: 10.1021/acschemneuro.7b00492. Epub 2017 Dec 29.

PMID:
29286622
12.

Building Bridges through Science.

Lissek T, Adams M, Adelman J, Ahissar E, Akaaboune M, Akil H, al'Absi M, Arain F, Arango-Lasprilla JC, Atasoy D, Avila J, Badawi A, Bading H, Baig AM, Baleriola J, Belmonte C, Bertocchi I, Betz H, Blakemore C, Blanke O, Boehm-Sturm P, Bonhoeffer T, Bonifazi P, Brose N, Campolongo P, Celikel T, Chang CC, Chang TY, Citri A, Cline HT, Cortes JM, Cullen K, Dean K, Delgado-Garcia JM, Desroches M, Disterhoft JF, Dowling JE, Draguhn A, El-Khamisy SF, El Manira A, Enam SA, Encinas JM, Erramuzpe A, Esteban JA, Fariñas I, Fischer E, Fukunaga I, Gabilondo I, Ganten D, Gidon A, Gomez-Esteban JC, Greengard P, Grinevich V, Gruart A, Guillemin R, Hariri AR, Hassan B, Häusser M, Hayashi Y, Hussain NK, Jabbar AA, Jaber M, Jahn R, Janahi EM, Kabbaj M, Kettenmann H, Kindt M, Knafo S, Köhr G, Komai S, Krugers H, Kuhn B, Ghazal NL, Larkum ME, London M, Lutz B, Matute C, Martinez-Millan L, Maroun M, McGaugh J, Moustafa AA, Nasim A, Nave KA, Neher E, Nikolich K, Outeiro T, Palmer LM, Penagarikano O, Perez-Otano I, Pfaff DW, Poucet B, Rahman AU, Ramos-Cabrer P, Rashidy-Pour A, Roberts RJ, Rodrigues S, Sanes JR, Schaefer AT, Segal M, Segev I, Shafqat S, Siddiqui NA, Soreq H, Soriano-García E, Spanagel R, Sprengel R, Stuart G, Südhof TC, Tønnesen J, Treviño M, Uthman BM, Venter JC, Verkhratsky A, Weiss C, Wiesel TN, Yaksi E, Yizhar O, Young LJ, Young P, Zawia NH, Zugaza JL, Hasan MT.

Neuron. 2017 Nov 15;96(4):730-735. doi: 10.1016/j.neuron.2017.09.028.

13.

Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.

Baig AM, Rana Z, Tariq S, Lalani S, Ahmad HR.

ACS Chem Neurosci. 2018 Mar 21;9(3):494-504. doi: 10.1021/acschemneuro.7b00254. Epub 2017 Nov 13.

PMID:
29058403
14.

Is There a Cholinergic Survival Incentive for Neurotropic Parasites in the Brain?

Baig AM.

ACS Chem Neurosci. 2017 Dec 20;8(12):2574-2577. doi: 10.1021/acschemneuro.7b00370. Epub 2017 Oct 6. Review.

PMID:
28985043
15.

Bioinformatic Insights on Target Receptors of Amiodarone in Human and Acanthamoeba castellanii.

Baig AM, Rana Z, Tariq SS, Ahmad HR.

Infect Disord Drug Targets. 2017;17(3):160-177. doi: 10.2174/1871526517666170622075154.

PMID:
28637420
16.

Antibiotic Effects of Loperamide: Homology of Human Targets of Loperamide with Targets in Acanthamoeba spp.

Baig AM, Rana Z, Mannan M, Tariq S, Ahmad HR.

Recent Pat Antiinfect Drug Discov. 2017;12(1):44-60. doi: 10.2174/1574891X12666170425170544.

PMID:
28506204
17.

Apoptosis in Acanthamoeba castellanii belonging to the T4 genotype.

Baig AM, Lalani S, Khan NA.

J Basic Microbiol. 2017 Jul;57(7):574-579. doi: 10.1002/jobm.201700025. Epub 2017 May 3.

PMID:
28466971
18.

Emerging Insights for Better Delivery of Chemicals and Stem Cells to the Brain.

Baig AM.

ACS Chem Neurosci. 2017 Jun 21;8(6):1119-1121. doi: 10.1021/acschemneuro.7b00106. Epub 2017 Apr 3.

PMID:
28367623
19.

Evidence of a M1-muscarinic GPCR homolog in unicellular eukaryotes: featuring Acanthamoeba spp bioinformatics 3D-modelling and experimentations.

Baig AM, Ahmad HR.

J Recept Signal Transduct Res. 2017 Jun;37(3):267-275. doi: 10.1080/10799893.2016.1217884. Epub 2016 Sep 7.

PMID:
27601178
20.

Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri.

Baig AM.

ACS Chem Neurosci. 2016 Aug 17;7(8):1026-9. doi: 10.1021/acschemneuro.6b00197. Epub 2016 Jul 22.

PMID:
27447543
21.

A proposed cascade of vascular events leading to granulomatous amoebic encephalitis.

Baig AM, Khan NA.

Microb Pathog. 2015 Nov;88:48-51. doi: 10.1016/j.micpath.2015.08.005. Epub 2015 Aug 11. Review.

PMID:
26276705
22.

Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response?

Baig AM.

Acta Trop. 2015 Aug;148:72-6. doi: 10.1016/j.actatropica.2015.04.022. Epub 2015 Apr 27. Review.

PMID:
25930186
23.

Eukaryotic cell encystation and cancer cell dormancy: is a greater devil veiled in the details of a lesser evil?

Baig AM, Khan NA, Abbas F.

Cancer Biol Med. 2015 Mar;12(1):64-7. doi: 10.7497/j.issn.2095-3941.2014.0028.

24.

Tackling infection owing to brain-eating amoeba.

Baig AM, Khan NA.

Acta Trop. 2015 Feb;142:86-8. doi: 10.1016/j.actatropica.2014.11.004. Epub 2014 Nov 13. Review.

PMID:
25445746
25.

Granulomatous amoebic encephalitis: ghost response of an immunocompromised host?

Baig AM.

J Med Microbiol. 2014 Dec;63(Pt 12):1763-6. doi: 10.1099/jmm.0.081315-0. Epub 2014 Sep 19. No abstract available.

PMID:
25239626
26.

Designer's microglia with novel delivery system in neurodegenerative diseases.

Baig AM.

Med Hypotheses. 2014 Oct;83(4):510-2. doi: 10.1016/j.mehy.2014.08.003. Epub 2014 Aug 11.

PMID:
25146247
27.

Laboratory testing of clinically approved drugs against Balamuthia mandrillaris.

Kalsoom H, Baig AM, Khan NA, Siddiqui R.

World J Microbiol Biotechnol. 2014 Sep;30(9):2337-42. doi: 10.1007/s11274-014-1658-4. Epub 2014 May 30.

PMID:
24875138
28.

Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.

Kulsoom H, Baig AM, Siddiqui R, Khan NA.

Exp Parasitol. 2014 Nov;145 Suppl:S115-20. doi: 10.1016/j.exppara.2014.03.025. Epub 2014 Apr 12.

PMID:
24726699
29.

Recommendations for the management of Acanthamoeba keratitis.

Baig AM, Zuberi H, Khan NA.

J Med Microbiol. 2014 May;63(Pt 5):770-1. doi: 10.1099/jmm.0.069237-0. Epub 2014 Feb 7. No abstract available.

PMID:
24509420
30.

Anesthesia with antiamoebic effects: can anesthesia choice affect the clinical outcome of granulomatous amoebic encephalitis due to Acanthamoeba spp.?

Baig AM, Khan NA.

J Neurosurg Anesthesiol. 2014 Oct;26(4):409-10. doi: 10.1097/ANA.0000000000000036. No abstract available.

PMID:
24504169
31.

Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against Naegleria fowleri.

Baig AM, Kulsoom H, Khan NA.

J Med Microbiol. 2014 May;63(Pt 5):760-2. doi: 10.1099/jmm.0.072306-0. Epub 2014 Feb 3. No abstract available.

PMID:
24493160
32.

Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri.

Baig AM, Khan NA.

CNS Neurosci Ther. 2014 Mar;20(3):289-90. doi: 10.1111/cns.12225. Epub 2014 Jan 24. No abstract available.

PMID:
24456292
33.

In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.

Baig AM, Iqbal J, Khan NA.

Antimicrob Agents Chemother. 2013 Aug;57(8):3561-7. doi: 10.1128/AAC.00299-13. Epub 2013 May 13.

34.

Intersession reliability of the electromyographic signal during incremental cycle ergometry: quadriceps femoris.

Travis LA, Arthmire SJ, Baig AM, Goldberg A, Malek MH.

Muscle Nerve. 2011 Dec;44(6):937-46. doi: 10.1002/mus.22211.

PMID:
22102465
35.

Distraction osteogenesis of a unilateral hypoplastic mandible.

Liaqat S, Baig AM, Bukhari SG, Ahmed W.

J Ayub Med Coll Abbottabad. 2011 Apr-Jun;23(2):174-6.

PMID:
24800374
36.
37.

Orofacial reconstruction with local flaps at AFID.

Liaqat B, Ehsan A, Baig AM, Bukhari SG.

J Ayub Med Coll Abbottabad. 2010 Oct-Dec;22(4):131-4.

PMID:
22455280

Supplemental Content

Support Center